Compounds > phosphatidylcholines
Page last updated: 2024-09-05

phosphatidylcholines and mdv 3100

phosphatidylcholines has been researched along with mdv 3100 in 1 studies

Compound Research Comparison

Studies
(phosphatidylcholines)		Trials
(phosphatidylcholines)		Recent Studies (post-2010)
(phosphatidylcholines)		Studies
(mdv 3100)		Trials
(mdv 3100)		Recent Studies (post-2010) (mdv 3100)
32,2044435,5931,5461821,502

Protein Interaction Comparison

ProteinTaxonomyphosphatidylcholines (IC50)mdv 3100 (IC50)
Gamma-aminobutyric acid receptor subunit piHomo sapiens (human)3
Gamma-aminobutyric acid receptor subunit deltaHomo sapiens (human)3
Prostate-specific antigenHomo sapiens (human)0.13
Androgen receptorHomo sapiens (human)0.8644
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)3
Androgen receptorRattus norvegicus (Norway rat)0.8238
Gamma-aminobutyric acid receptor subunit beta-1Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)3
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)1.26
Gamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-5Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-4Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit epsilonHomo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-6Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-1Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit thetaHomo sapiens (human)3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
He, Y; Huang, H; Niu, Y; Quan, C; Wang, L; Wen, S; Zhang, J1

Other Studies

1 other study(ies) available for phosphatidylcholines and mdv 3100

ArticleYear
Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer.
    Oncogene, 2020, Volume: 39, Issue:42

    Topics: Androgen Antagonists; Androgens; Animals; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Choline Kinase; Chromatin Immunoprecipitation Sequencing; Diacylglycerol Cholinephosphotransferase; Drug Resistance, Neoplasm; Enhancer Elements, Genetic; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Nitriles; Phenylthiohydantoin; Phosphatidylcholines; Prostate; Prostatectomy; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; RNA, Long Noncoding; Signal Transduction; Transcription Factors; Transcription, Genetic; Xenograft Model Antitumor Assays

2020